AF
GILD icon

AGP Franklin’s Gilead Sciences GILD Stock Holding History

AGP Franklin’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.72M Buy
12,369
+584
+5% +$81.8K 0.86% 39
2025
Q4 		$1.45M Buy
11,785
+637
+6% +$77.4K 0.68% 48
2025
Q3 		$1.24M Buy
+11,148
New +$1.27M 0.6% 53

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AGP Franklin's GILD Position: Q1 2026 in Review

AGP Franklin increased its Gilead Sciences (GILD) stake by 5% in Q1 2026, buying an estimated $81.8K and bringing the position to 12,369 shares worth $1.72M. The position accounts for 0.86% of the portfolio, ranked #39.

AGP Franklin first reported a position in GILD in Q3 2025 and has held it in 3 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • AGP Franklin held 12,369 shares of Gilead Sciences worth $1.72M as of Q1 2026.
  • AGP Franklin bought 584 Gilead Sciences shares in Q1 2026, an estimated $81.8K.
  • Gilead Sciences made up 0.86% of AGP Franklin's portfolio in Q1 2026, its #39 holding.
  • AGP Franklin first reported a position in Gilead Sciences in Q3 2025 and has held it in 3 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AGP Franklin's 13F filing for Q1 2026, filed 17 Apr 2026.